台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-華南永昌-楠梓 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-楠梓 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20041.9900.0041.6503780.00%
2025/01/15042.3000.0042.1503810.01%
2025/01/0900.00144.6043.95-1386-0.26%
2024/12/1100.00543.5143.10-5592-0.84%
2024/12/09243.4500.0043.8026000.33%
2024/12/05045.5000.0045.1506160.00%
2024/12/0400.00144.9545.35-1620-0.16%
2024/12/03145.7900.0045.2516290.16%
2024/11/29145.25145.2546.0506390.00%
2024/11/26345.1000.0045.0536600.45%
2024/11/20245.2000.0045.1026820.29%
2024/11/15546.4500.0046.2556960.72%
2024/11/06149.5000.0049.3517460.13%
2024/10/2500.00253.1054.40-2645-0.31%
2024/10/22049.5500.0049.6006460.00%
2024/10/17552.0000.0050.5058500.59%
2024/10/1400.000.849.8650.40-0.81,057-0.08%
2024/10/0700.00152.0052.10-11,052-0.09%
2024/09/30154.4000.0054.4011,0460.10%
2024/09/2700.00154.4054.70-11,035-0.10%
2024/09/2600.00153.4051.90-11,023-0.10%
2024/09/2500.00353.7753.80-31,018-0.29%
2024/09/24255.4000.0053.4021,0190.20%
2024/09/19155.0000.0053.2019950.10%
2024/09/1300.001048.2447.80-10967-1.03%
2024/09/0500.00147.6547.40-11,018-0.10%
2024/09/03151.5000.0051.4011,0070.10%
2024/08/2600.00149.5049.65-1971-0.10%
2024/08/23148.6500.0049.3519660.10%
2024/08/1300.00547.0047.10-5894-0.56%
2024/08/08149.30149.9049.7508650.00%
2024/08/0700.00250.7550.70-2856-0.23%
2024/08/06148.5000.0049.0018410.12%
2024/08/05547.7600.0047.7058180.61%
2024/08/0100.00455.4055.40-4804-0.50%
2024/07/31456.60455.8056.5007990.00%
2024/07/29457.5000.0056.9047880.51%
2024/07/26354.8000.0054.5037760.39%
2024/07/23153.902053.8054.10-19770-2.46%
2024/07/2200.00159.2056.20-1752-0.13%
2024/07/19259.70158.9058.1017350.14%
2024/07/18262.15363.3062.20-1658-0.15%
2024/07/17658.3000.0058.9065431.10%
2024/07/16656.83257.2057.2044270.94%
2024/07/1500.00252.0052.00-2337-0.59%
2024/07/09043.4800.0043.4003190.00%
2024/06/28148.1000.0047.1012990.33%
2024/06/27148.35147.7047.1002960.00%
2024/06/2600.00248.0048.75-2288-0.69%
2024/06/24145.9500.0045.5012620.38%
2024/06/20248.83147.9547.6012500.40%
2024/06/1900.00047.4547.950224-0.01%
2024/06/17045.15245.2045.35-2187-1.05%
2024/05/2300.00142.2542.10-1172-0.58%
2024/05/22143.3000.0043.2511740.57%
2024/05/1700.00042.0042.4501770.00%
2024/05/0800.00342.0041.60-3180-1.66%
2024/04/24240.9000.0041.1021831.09%
2024/04/22040.70040.8040.6501870.01%
2024/04/19041.0000.0040.7001860.00%
2024/04/17042.4500.0041.7501830.00%
2024/03/20041.5000.0041.5501980.00%
2024/03/14043.0000.0042.9002050.00%
2024/03/13042.5800.0042.6002090.00%
2024/03/01044.8500.0044.2503440.00%
2024/02/29044.9200.0044.8503660.00%
2024/02/1600.00246.8046.75-2426-0.47%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音